Form 4 for TCRT Alaunos Therapeutics, Inc.
Accepted 2025-04-15 00:00:00 ET · period of report 2025-04-11 · accession 0000950170-25-054436 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-04-15 | 2025-04-13 | TCRT | Postma Robert W | Dir | A - Grant | $2.92 | +20.8K | 29.1K | +251% | +$60.7K |
| DI | 2025-04-15 | 2025-04-11 | TCRT | Postma Robert W | Dir | P - Purchase | $2.76 | +500 | 500 | New | +$1,380 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-04-13 | A | A | 20,804 | $2.92 | 29,083 | D | — | — | |
| 2 | Derivative | Series A-1 Convertible Preferred Stock | 2025-04-11 | P | A | 500 | $2.76 | 500 | I By WaterMill Asset Management Corp. | $2.76 · 2025-04-11 to — | 181,159 Common Stock | (F1) The shares are directly held by WaterMill Asset Management Corp. ("WaterMill"). The Reporting Person serves as the principal of WaterMill. (F2) The preferred stock is perpetual and therefore has no expiration date. |